Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class ASSE: 688505

Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference

Apr 29, 2026 · Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Attending the 2025 Pharmaceutical Industry Collective Performance Briefing for the “15th Five-Year Plan” Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of FZ-P001 Sodium for Injection for Visualization of Malignant Lesions during Ovarian Cancer SurgeryApr 10
Announcement on Requesting the General Meeting to Authorize the Board of Directors to Issue Shares to Specific Objects by Summary ProcedureMar 31
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Change of Sponsor Representative for Continuous SupervisionFeb 10

All Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A news releases